SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,492,000 | +344.0% | 41,421 | +326.7% | 0.00% | – |
| Q1 2022 | $336,000 | -72.6% | 9,708 | -65.7% | 0.00% | -100.0% |
| Q4 2021 | $1,226,000 | -86.3% | 28,340 | -85.7% | 0.00% | -75.0% |
| Q3 2021 | $8,922,000 | +3318.4% | 198,122 | +5763.3% | 0.00% | – |
| Q1 2021 | $261,000 | -13.0% | 3,379 | +2.4% | 0.00% | – |
| Q4 2020 | $300,000 | +37.6% | 3,299 | -3.4% | 0.00% | – |
| Q3 2020 | $218,000 | -77.3% | 3,415 | -84.3% | 0.00% | -100.0% |
| Q2 2020 | $961,000 | +3103.3% | 21,817 | +1865.5% | 0.00% | – |
| Q1 2020 | $30,000 | -86.4% | 1,110 | -63.7% | 0.00% | – |
| Q4 2019 | $221,000 | -84.8% | 3,057 | -70.5% | 0.00% | -100.0% |
| Q3 2019 | $1,455,000 | -47.1% | 10,371 | -31.0% | 0.00% | -50.0% |
| Q2 2019 | $2,753,000 | +213.9% | 15,039 | +172.7% | 0.00% | +100.0% |
| Q1 2019 | $877,000 | +47.1% | 5,515 | -11.2% | 0.00% | 0.0% |
| Q4 2018 | $596,000 | -31.3% | 6,213 | +1.1% | 0.00% | 0.0% |
| Q3 2018 | $868,000 | +10.0% | 6,147 | +21.9% | 0.00% | 0.0% |
| Q2 2018 | $789,000 | +1215.0% | 5,042 | +1251.7% | 0.00% | – |
| Q1 2018 | $60,000 | +9.1% | 373 | +11.0% | 0.00% | – |
| Q4 2017 | $55,000 | +816.7% | 336 | +236.0% | 0.00% | – |
| Q3 2017 | $6,000 | -62.5% | 100 | -51.0% | 0.00% | – |
| Q2 2017 | $16,000 | -98.1% | 204 | -98.3% | 0.00% | -100.0% |
| Q1 2017 | $853,000 | +10562.5% | 12,006 | +7004.1% | 0.00% | – |
| Q4 2016 | $8,000 | +300.0% | 169 | +213.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 54 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -50.0% | 54 | -60.0% | 0.00% | – |
| Q1 2016 | $4,000 | -50.0% | 135 | 0.0% | 0.00% | – |
| Q4 2015 | $8,000 | +33.3% | 135 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | -95.9% | 135 | -93.2% | 0.00% | – |
| Q2 2015 | $146,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |